spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  medroxyprogesterone 

 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 24 Sep 2015
Pfizer’s Sayana(R) Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Jul 2009
Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jun 2009
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Apr 2008
KV Begins Shipping Evamist(TM) to Wholesalers
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2007
Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 May 2007
Wyeth Wins Philadelphia Hormone Therapy Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine
 HSMN NewsFeed - 18 Dec 2006
BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Oct 2006
Wyeth Responds to Mistrial in Philadelphia Hormone Therapy Case
Biopharmaceuticals Litigation
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
medroxyprogesterone
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.